Ursodeoxycholic Acid Protects against Secondary Biliary Cirrhosis in Rats by Preventing Mitochondrial Oxidative Stress

Hepatology

Volumn 39, Issue 3, 2004, Pages 711-720

  Serviddio, Gaetano ^a,b   Pereda, Javier ^b   Pallardó, Federico V ^b   Carretero, Julian ^b   Borras, Consuelo ^b   Cutrin, Juan ^c   Vendemiale, Gianluigi ^a   Poli, Giuseppe ^c   Viña, José ^b   Sastre, Juan ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; CARDIOLIPIN; CYSTATHIONINE GAMMA LYASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; LIVER PROTEIN; MESSENGER RNA; PEROXIDE; PHOSPHATIDYLSERINE; URSODEOXYCHOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BILIARY CIRRHOSIS; BILIARY EXCRETION; BIOSYNTHESIS; CELL DAMAGE; CELL LEVEL; CELL POPULATION; CELL PROTECTION; CHOLESTASIS; CONTROLLED STUDY; DEPLETION; DRUG EFFECT; DRUG MECHANISM; ENZYME REGULATION; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER LEVEL; LIVER PROTECTION; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SURVIVAL RATE; UPREGULATION;

ANIMALS; CARDIOLIPINS; CHOLESTASIS; CHRONIC DISEASE; CYSTATHIONINE GAMMA-LYASE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HEPATOCYTES; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MEMBRANE POTENTIALS; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDES; RATS; RATS, WISTAR; URSODEOXYCHOLIC ACID;

EID: 12144286014     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20101     Document Type: Article

References (48)

1. Scharschmidt BF. Bile formation and cholestasis. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. Philadelphia: W.B. Saunders, 1990:303-304.
2. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-1580.
3. Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 1991;324:1548-1554.
4. Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, Coppel RL. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000;174:210-225.
5. Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM jr. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 1995;109:1249-1256.
6. Galle PR, Theilmann L, Raedsch R, Otto G, Stiehl A. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. HEPATOLOGY 1990;12:486-491.
7. Scheuer PJ. Liver Biopsy Interpretation. 3rd ed. London: Balliere Tindall, 1980:36-59.
8. Ratan RR, Murphy TH, Baraban JM. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 1994;62:376-379.
9. Verhaegen S, McGowan AJ, Brophy AR, Fernandes RS, Cotter TG. Inhibition of apoptosis by antioxidants in the human HL-60 leukemia cell line. Biochem Pharmacol 1995;50:1021-1029.
10. Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998;101:2790-2799.
11. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoprosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998;4:165-178.
12. Sokol RJ, McKim JM Jr., Goff MC, Ruyle SZ, Devereaux MW, Han D, Packer L, et al. Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology 1998;114:164-174.
13. Sokol RJ, Devereaux MW, Khandwala R. Effect of oxypurinol, a xanthine oxidase inhibitor, on hepatic injury in the bile duct-ligated rat. Pediatr Res 1998;44:397-401.
14. Tsai LY, Lee KT, Liu TZ. Evidence for accelerated generation of hydroxyl radicals in experimental obstructive jaundice of rats. Free Radic Biol Med 1998;24:732-737.
15. Krahenbuhl S, Talos C, Fischer S, Reichen J. Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria. HEPATOLOGY 1994;19:471-479.
16. Bernardi P. The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1996;1275:5-9.
17. Botla R, Spivey JR, Aguilar H, Bronk SF, Gores GJ. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther 1995;272:930-938.
18. Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. HEPATOLOGY 2001; 33:616-626.
19. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J Hepatol 2001;35: 134-146.
20. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997; 113:884-890.
21. Guldutuna S, Zimmer G, Imhof M, Bhatti S, You T, Leuschner U. Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology 1993;104:1736-1744.
22. Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, Dombrowski F. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. HEPATOLOGY 2001;33:1206-1216.
23. Qiao L, Yacoub A, Studer E, Gupta S, Pei XY, Grant S, Hylemon PB, et al. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. HEPATOLOGY 2002;35:779-789.
24. Mitsuyoshi H, Nakashima T, Sumida Y, Yoh T, Nakajima Y, Ishikawa H, Inaba K. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem Biophys Res Commun 1999; 263:537-542.
25. Rodriguez-Ortigosa CM, Cincu RN, Sanz S, Ruiz F, Quiroga J, Prieto J. Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats. Gut 2002;50:701-706.
26. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press, 1997.
27. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984;65: 305-311.
28. Miñana JB, Gomez-Cambronero L, Lloret A, Pallardo FV, Del Olmo J, Escudero A, Rodrigo JM. Mitochondrial oxidative stress and CD95 ligand: a dual mechanism for hepatocyte apoptosis in chronic alcoholism. HEPATOLOGY 2002;35:1205-1214.
29. Barja G. Measurement of mitochondrial oxygen radical production. In: Yu BP, ed. Methods in Aging Research. Boca Raton: CRC Press, 1999:533-548.
30. Romero F, Viña J. A simple procedure to prepare isolated hepatocytes. Biochem Educ 1983;11:135-136.
31. Juan G, Cavazzoni M, Saez GT, O'Connor JE. A fast kinetic method for assessing mitochondrial membrane potential in isolated hepatocytes with rhodamine 123 and flow cytometry. Cytometry 1994;15:335-342.
32. Petit PX, O'Connor JE, Grunwald D, Brown SC. Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. Eur J Biochem 1990;194:389-397.
33. Maftah A, Petit JM, Ratinaud MH, Julien R. 10-N nonyl-acridine orange: a fluorescent probe which stains mitochondria independently of their energetic state. Biochem Biophys Res Commun 1989;164:185-190.
34. Viña J, Hems R, Krebs HA. Reaction of formiminoglutamate with liver glutamate dehydrogenase. Biochem J 1978;170:711-713.
35. Lu SC, Kuhlenkamp J, Garcia-Ruiz C, Kaplowitz N. Hormone-mediated down-regulation of hepatic glutathione synthesis in the rat. J Clin Invest 1991;88:260-269.
36. Tateishi N, Higashi T, Shinya S, Naruse A, Sakamoto Y. Studies on the regulation of glutathione level in rat liver. J Biochem (Tokyo) 1974;75: 93-103.
37. Halestrap AP, Woodfield KY, Connern CP. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 1997;272:3346-3354.
38. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 2002;286:135-141.
39. Singh S, Shackleton G, Ah-Sing E, Chakraborty J, Bailey ME. Antioxidant defenses in the bile duct-ligated rat. Gastroenterology 1992;103:1625-1629.
40. Krahenbuhl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. HEPATOLOGY 1995;22:607-612.
41. Muriel P, Suarez OR, Gonzalez P, Zuniga L. Protective effect of S-adenosyl-L-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol 1994;21: 95-102.
42. Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, Bain RP, Chawla RK. Evidence for impairment of transsulfurarion pathway in cirrhosis. Gastroenterology 1981;81:668-675.
43. Look MP, Gerard A, Rao GS, Sudhop T, Fischer HP, Sauerbruch T, Spengler U. Interferon/antioxidant combination therapy for chronic hepatitis C-a controlled pilot trial. Antiviral Res 1999;43:113-122.
44. Avila MA, Berasain C, Torres L, Martin-Duce A, Corrales FJ, Yang H, Prieto J. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol 2000;33:907-914.
45. 2+ content by the ADP/ATP carrier in brown adipose tissue mitochondria. Influence of membrane lipid composition. J Bioenerg Biomembr 1996;28:69-76.
46. Lieser MJ, Park J, Narori S, Jones BA, Bronk SF, Gores GJ. Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology 1998;115:693-701.
47. Esteve JM, Mompo J, Garcia de Asunción, Sastre J, Asensi M, Boix J, Viña JR. Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: studies in vivo and in vitro. FASEB J 1999;13:1055-1064.
48. Corpechot C, Carrat F, Bonnad AM, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. HEPATOLOGY 2000;32:1196-1199.